Analyst’s Disclosure: I/we have a beneficial long position in the shares of ESI:CA; PTEN; NBR either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. My articles, blog posts, and comments on this platform do not constitute investment recommendations, but rather express my person ...

CALGARY, Alberta, May 15, 2025 (GLOBE NEWSWIRE) -- Precision Drilling Corporation (Precision or the Company) is pleased to announce the results of the election of board members at its 2025 Annual and Special Meeting of Shareholders held on May 15, 2025 (the Annual Meeting). Shareholders approved the election of all eight (seven of whom are independent) of the nominee directors presented in the Company’s Management Information Circular (the Circular), dated April 2, 2025. The shares represented at the Annual ...

VERSATILE-003 Phase 3 Site Initiations Underway Multiple Abstracts Selected for Presentation at the 2025 American Society of Clinical Oncology Annual Meeting Conference call and webcast today at 8:00 a.m. Eastern Time PRINCETON, N.J., May 14, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today provided a clinical and corporate update and report ...

CALGARY, Alberta, May 02, 2025 (GLOBE NEWSWIRE) -- Precision Drilling Corporation (Precision) would like to remind shareholders that it is holding its 2025 Annual and Special Meeting of Shareholders (the Annual Meeting) on Thursday, May 15, 2025 at 10:00 a.m. MST. As previously announced, the Annual Meeting will be held in a virtual-only meeting format. The meeting format will provide all shareholders an equal opportunity to participate in the Annual Meeting regardless of their geographic location. The Annu ...

Financial Data and Key Metrics Changes - Adjusted EBITDA for Q1 2025 was $137 million, a decrease from $143 million when excluding share-based compensation and restructuring charges [6][7] - Revenue for the quarter was $496 million, a decrease of 6% from Q1 2024 [7] - Net earnings were $35 million or $2.52 per share, marking the 11th consecutive quarter of positive earnings [8] - Funds from operations were $110 million, with cash provided by operations at $63 million [8] - Long-term debt position net of cash was approximately $778 million, with a net debt to trailing 12-month EBITDA ratio of approximately 1.5x [17][18] Business Line Data and Key Metrics Changes - In the U.S., drilling activity averaged 30 rigs in Q1, a decrease of 4 rigs from the previous quarter, with daily operating margins at US$8,360, down US$787 from Q4 [8][9] - Canadian drilling activity averaged 74 rigs, an increase of 1 rig from Q1 2024, with daily operating margins at $14,779, a decrease of $858 from Q1 2024 [13] - Internationally, drilling activity averaged 8 rigs, with average day rates at US$49,419, a decrease of 6% from the prior year [14] Market Data and Key Metrics Changes - U.S. daily operating costs were unusually high due to rig activations and mobilizations, with expected normalized margins between US$7,000 and US$8,000 for Q2 [9][10] - In Canada, the market remains strong with LNG Canada’s first shipments imminent, supporting long-term stability in the Montney region [27][30] Company Strategy and Development Direction - The company plans to maintain a strong presence in key regions while managing costs effectively to drive down operating costs throughout 2025 [11][12] - Capital expenditures for Q1 were $60 million, with a full-year capital plan reduced from $225 million to $200 million [15][40] - The company aims to reduce debt by $700 million between 2022 and 2027, with a target of $100 million for 2025 [19][20] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding customer sentiment in the U.S. and Canada, with ongoing interest in gas-directed drilling despite macroeconomic uncertainties [24][36] - The company is focused on free cash flow and maintaining capital discipline while being well-positioned for emerging opportunities [25][34] - Management noted that customers are managing costs tightly and are in a strong financial position, which supports ongoing drilling programs [29][30] Other Important Information - The company exited the North Dakota market due to competitive pressures and is reallocating resources back to Canada [32] - The company has recognized a $230 million balance on its 2026 note as current debt and plans to reduce this balance by at least $80 million in the last three quarters of the year [18] Q&A Session Summary Question: Thoughts on performance model versus day rate model - Management prefers the a la carte style of base rate for rigs, with about one-third of U.S. rigs under performance contracts [50][51] Question: Rationale for continuing debt reduction over stock buybacks - Management emphasizes a commitment to deleveraging and maintaining a strong capital structure, targeting a net debt to EBITDA ratio below 1x [55][56] Question: Impact of capital expenditure reduction on free cash flow - Management is confident in meeting capital allocation guidance and is focused on managing cash outflows tightly [62] Question: Changes in U.S. margins and impact of restructuring - Management expects margins to improve as fixed costs decrease with increased rig activity [66][67] Question: Rig mobilization and reactivation costs - Typical costs for rig mobilization or reactivation range from $500,000 to $1 million [75][76] Question: Impact of tariffs on capital and operating costs - Tariffs primarily affect drill pipe costs, but management believes they can manage the impact effectively [84][86] Question: Pricing pressures in Canada - Management acknowledges ongoing pricing pressures from customers but expects to manage margins effectively [93][94]

Precision Drilling (PDS) Q1 2025 Earnings Call April 24, 2025 01:00 PM ET Company Participants Lavonne Zdunich - Vice President of Investor RelationsCarey Ford - Chief Financial OfficerKevin Neveu - President , CEO & DirectorKeith Mackey - Director - Global Equity Research, Oil & Gas ServicesWaqar Syed - MD & Head of ResearchJohn Gibson - Director - Equity ResearchJohn Daniel - Founder & CEOAaron Rosenthal - Executive Director Conference Call Participants Aaron MacNeil - Director, Equity Research Analyst Op ...

Core Viewpoint - Precision Drilling reported quarterly earnings of $1.53 per share, missing the Zacks Consensus Estimate of $1.57 per share, and down from $1.88 per share a year ago, indicating a negative earnings surprise of -2.55% [1][2] Financial Performance - The company posted revenues of $345.72 million for the quarter, missing the Zacks Consensus Estimate by 0.85%, and down from $391.51 million year-over-year [2] - Over the last four quarters, Precision Drilling has surpassed consensus EPS estimates two times and topped revenue estimates only once [2] Stock Performance - Precision Drilling shares have declined approximately 29.6% since the beginning of the year, compared to a decline of -10.1% for the S&P 500 [3] - The stock currently holds a Zacks Rank 5 (Strong Sell), indicating expectations of underperformance in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.22 on revenues of $293.72 million, and for the current fiscal year, it is $5.13 on revenues of $1.34 billion [7] - The estimate revisions trend for Precision Drilling has been unfavorable ahead of the earnings release [6] Industry Context - The Oil and Gas - Drilling industry is currently ranked in the bottom 14% of over 250 Zacks industries, suggesting a challenging environment for stocks in this sector [8]

Core Insights - Precision Drilling Corporation reported its first quarter results for 2025, highlighting a decrease in revenue and adjusted EBITDA compared to the same period in 2024, while maintaining a commitment to shareholder returns and debt reduction [2][8][18]. Financial Highlights - Revenue for Q1 2025 was $496 million, down 6% from $528 million in Q1 2024 [8][13]. - Adjusted EBITDA decreased to $137 million from $143 million year-over-year, reflecting a 3.9% decline [8][13]. - Net earnings attributable to shareholders were $35 million, or $2.52 per share, compared to $37 million, or $2.53 per share in the previous year [8][13][18]. - Cash provided by operations was $63 million, enabling the company to repurchase $31 million in shares and reduce debt by $17 million [8][18][27]. Operational Highlights - Canadian drilling activity averaged 74 active rigs, slightly up from 73 in 2024, while U.S. activity averaged 30 rigs, down from 38 [6][14]. - Revenue per utilization day in Canada was $35,601, consistent with the previous year, while U.S. revenue per utilization day was $33,157, a 0.9% increase [8][14]. - Service rig operating hours decreased by 10% due to project deferrals and an earlier spring breakup [8][15]. Strategic Initiatives - The company has reduced its 2025 capital budget to $200 million from the previously announced $225 million, reflecting a cautious approach amid market uncertainty [9][26]. - Precision aims to allocate 35% to 45% of free cash flow before debt repayments to share buybacks, with a commitment to repaying at least $100 million of debt in 2025 [8][27]. - The company is focused on maximizing free cash flow through disciplined capital deployment and strict cost management [20][27]. Industry Outlook - Near-term expectations for global energy demand growth are tempered by geopolitical events, but long-term fundamentals remain positive due to economic growth and increasing demand from emerging economies [21][22]. - In Canada, the operationalization of the Trans Mountain pipeline and LNG Canada is expected to support drilling activity [22][23]. - The U.S. is anticipated to see increased natural gas drilling activity due to significant LNG export capacity expansion [24][25].

Company Overview - Precision Drilling Corporation is a leading provider of safe and environmentally responsible services to the energy industry, offering access to an extensive fleet of Super Series drilling rigs [4] - The company has commercialized an industry-leading digital technology portfolio known as Alpha™, which utilizes advanced automation software and analytics to deliver efficient, predictable, and repeatable results for energy customers [4] - Precision also provides well service rigs, camps, and rental equipment, supported by a comprehensive mix of technical support services and skilled personnel [4] Upcoming Financial Results - Precision intends to release its 2025 first quarter results after the market closes on April 23, 2025 [1] - A conference call is scheduled for April 24, 2025, at 11:00 a.m. MT (1:00 p.m. ET) to discuss the results [1] - Participants can register for the conference call to receive a dial-in number and unique PIN for questions [1][2] Additional Information - Precision is headquartered in Calgary, Alberta, Canada, and is listed on the Toronto Stock Exchange under the symbol "PD" and on the New York Stock Exchange under "PDS" [5] - For more information, the company can be contacted through its Vice President of Investor Relations, Lavonne Zdunich [6]

Core Viewpoint - PDS Biotechnology Corporation is actively engaging with investors and the scientific community through upcoming presentations, highlighting its focus on immunotherapy for cancer treatment, particularly its lead program targeting advanced HPV16-positive head and neck squamous cell cancers [1][3]. Presentation Details - PDS Biotech's CEO, Frank Bedu-Addo, will present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13, 2025, at 2:30 PM ET [2]. - The company will also present at the 2025 CAGLA NeauxCancer Conference in New Orleans on March 28-29, 2025, during the Innovation Track session at 4:00 PM ET [2]. Company Overview - PDS Biotechnology is a late-stage immunotherapy company focused on transforming immune responses to target and kill cancers [3]. - The company has initiated a pivotal clinical trial for its lead investigational immunotherapy, Versamune® HPV, in combination with a standard immune checkpoint inhibitor and a triple combination including PDS01ADC, an IL-12 fused antibody drug conjugate [3].